0
Skip to Content
Elahi Lab
Science
What we do
Publications
Media
Funding
Our Research
Overview
Tumor Microenvironment
Immunotherapy
Socio-scientific
Lab in Photos
Awards & Recognitions
About Us
Principal Investigator
Team Members
Former Lab Members
Lab Facilities
Recruitment
Contact Us
Elahi Lab
Science
What we do
Publications
Media
Funding
Our Research
Overview
Tumor Microenvironment
Immunotherapy
Socio-scientific
Lab in Photos
Awards & Recognitions
About Us
Principal Investigator
Team Members
Former Lab Members
Lab Facilities
Recruitment
Contact Us
Folder: Science
Back
What we do
Publications
Media
Funding
Folder: Our Research
Back
Overview
Tumor Microenvironment
Immunotherapy
Folder: Socio-scientific
Back
Lab in Photos
Awards & Recognitions
Folder: About Us
Back
Principal Investigator
Team Members
Former Lab Members
Lab Facilities
Recruitment
Contact Us
  • Elahi Lab Reasearch - The sickest long COVID patients face symptoms identical to chronic fatigue syndrome

    The sickest long COVID patients face symptoms identical to chronic fatigue syndrome

    Telltale amino acid deficiencies may hold the key to new treatments, say researchers.

    FEBRUARY 08, 2024 BY GILLIAN RUTHERFORD

    Read more
  • Elahi Lab Reasearch - Sex matters when it comes to immune responses against infection and disease, study shows

    Sex matters when it comes to immune responses against infection and disease, study shows

    U of A immunologist leads new research showing how anemia can generate different immune responses in males versus females.


    OCTOBER 12, 2021 BY ROSS NEITZ

    Read more
  • Elahi Lab Reasearch - Common medication used to treat patients following COVID-19 may benefit them by reducing virus target cells

    Common medication used to treat patients following COVID-19 may benefit them by reducing virus target cells

    By helping immature red blood cells mature faster, dexamethasone may help reduce infectivity, U of A scientists say

    APRIL 09, 2021 BY RYAN O’BYRNE

    Read more
  • Elahi Lab Reasearch - New study reveals why HIV remains in human tissue even after antiretroviral therapy

    New study reveals why HIV remains in human tissue even after antiretroviral therapy

    Discovery could open the door to new treatments that improve our immune system’s ability to eliminate the stubborn virus.

    MARCH 25, 2022 BY TARWINDER RAI

    Read more
  • Elahi Lab Research - U of A researcher discovers marker that may predict response to cancer immunotherapy

    U of A researcher discovers marker that may predict response to cancer immunotherapy

    Abundance of a protein called galectin-9 in cancer patients found to be associated with poor response to immunotherapy.

    MAY 07, 2021 BY ADRIANNA MACPHERSON

    Read more
  • Elahi Lab Research - Researchers find possible culprit of inflammation that causes death in COVID-19 patients

    Researchers find possible culprit of inflammation that causes death in COVID-19 patients

    Blood plasma protein galectin-9 linked to ‘cytokine storms’ that damage organs and tissue, U of A team study finds.


    AUGUST 04, 2021 BY RYAN O’BYRNE

    Read more
  • Elahi Lab Research - University of Alberta study offers hope for people with HIV

    University of Alberta study offers hope for people with HIV

    Get the latest from Keith Gerein straight to your inbox

    FEB 17, 2016 BY KEITH GEREIN

    Read More
Elahi lab at the University of Alberta

Elahi Lab